|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Cash flows from operating activities: | |
| Net Income Loss | |
| Adjustment to reconcile net income (loss) to net cash used in operating activities: | |
| Interest earned on marketable securities held in trust account | |
| Gain on expiration of over-allotment option liability | |
| Changes in operating assets and liabilities: | |
| Prepaid expenses | |
| Accounts payable and accrued expenses | |
| Net Cash Used in Operating Activities | |
| Cash Flows from Investing Activities: | |
| Purchase of investment held in trust account | |
| Net Cash Used in Investing Activities | |
| Cash Flows from Financing Activities: | |
| Proceeds from Sale of Public Units | |
| Proceeds from sale of private placement units | |
| Proceeds from issuance of promissory note to related party | |
| Repayment of promissory note to related party | |
| Payment of underwriter commissions | |
| Payment of offering costs | |
| Advance from a related party | |
| Net Cash Provided by Financing Activities | |
| Net Change in Cash | |
| Cash, End of Year | |
| Supplemental disclosure of cash flow information: | |
| Deferred underwriting fee payable | |
| Accretion of carrying value to redemption value of Class A redeemable ordinary shares | |
| Deferred offering costs paid via promissory note – related party |
Loading...
